SEACROSS

Live / Registered — Registered (as of 14 Feb 2023)

What this means for you

Registered since 14 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90727451
Registration number
6976777
Mark type
Word mark
Filed
21 May 2021
Published for opposition
29 Nov 2022
Registered
14 Feb 2023
Attorney of record
Michael J. Turgeon

Goods and services

  • Class 005 — Pharmaceuticals: Chemical contraceptives; drugs for medical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; bacterial preparations for medical and veterinary use; bouillons for bacteriological cultures; biochemical medicines, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; prepared Chinese medicine, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; antibiotics; diagnostic preparations for medical purposes; medicines for human purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; medicines for dental purposes; chemical preparations for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; chemical preparations for pharmaceutical purposes, namely, contrast agents; chemical preparations for pharmaceutical purposes, namely, antidote; syrups for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; capsules for medicines, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; pharmaceutical preparations, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; chemico-pharmaceutical preparations, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; collyrium; biological preparations for medical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; lotions for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; medicinal tea; vaccines; food for babies; dietetic substances being fatty milk, omega-3 fish oil, amino acids, glucose, electrolytes, proteins, fats, carbohydrates, vitamins, trace elements, dietary fiber, and unsaturated fatty acids, all adapted for medical use; nutritional supplements; air purifying preparations; protein supplements for animals; medicines for veterinary purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; pesticides; dressings, medical; dental lacquer

Owner

Prosecution history

  • 14 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 14 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
  • 29 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 29 Nov 2022 — PUBLISHED FOR OPPOSITION
  • 09 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 26 Oct 2022 — ELECTRONIC RECORD REVIEW COMPLETE
  • 21 Oct 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
  • 17 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 26 Jul 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 26 Jul 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 26 Jul 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 07 Feb 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 07 Feb 2022 — NON-FINAL ACTION E-MAILED
  • 07 Feb 2022 — NON-FINAL ACTION WRITTEN
  • 02 Feb 2022 — ASSIGNED TO EXAMINER

View this trademark record on Marksy